Cerebrospinal Fluid Distribution and Pharmacokinetics of Ponatinib in Ph1-positive Acute Lymphoblastic Leukemia
Blood(2024)
Abstract
Tyrosine kinase inhibitors have improved outcomes in Philadelphia-positive ALL, but their efficacy in CNS disease remains uncertain. Ponatinib was studied for CNS distribution in 22 samples from 16 patients. CSF concentrations fell below the 40nM threshold, suggesting suboptimal CNS exposure.
MoreTranslated text
Key words
Ponatinib,ALL,CNS involvement,CSF,BCR::ABL1
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined